The Official Comment of AHRMM to the United States Department of Health and Human Services Food and Drug Administration (FDA) regarding Unique Device Identification for Medical Devices Docket No. FDA-2011-N-0090
AHRMM comments to the FDA regarding an amendment to the UDI proposed rule to address the UDI implementation time frame required by the 2012 Food and Drug Administration Safety and Innovation Act (FDASIA).
Related Resources
Webcast
The intersection of CQO is patient care, Deborah Rey presents ten commandments you should adopt if they're not already part of your values both…
On-Demand Educational Webinars
In order to become data-driven organizations, healthcare providers need to leverage data standards and information technology.
On-Demand Educational Webinars
Supply chain leaders are being charged with mission-critical tasks that require C-suite level engagement and buy-in. In this webinar, we discuss how…
On-Demand Educational Webinars
On-site supply storage is one of the core competencies of effective supply chain management, and adhering to standards and regulations is an ongoing…
On-Demand Educational Webinars
Health care costs continue to rise at an alarming rate, growing well ahead of inflation. In this webinar, we compare and contrast the education and…